Acetylcholinesterase Inhibitors Reduce Neuroinflammation and -Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model
Open Access
- 3 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e62679
- https://doi.org/10.1371/journal.pone.0062679
Abstract
Exogenous stress like tissue damage and pathogen invasion during surgical trauma could lead to a peripheral inflammatory response and induce neuroinflammation, which can result in postoperative cognitive dysfunction (POCD). The cholinergic anti-inflammatory pathway is a neurohumoral mechanism that plays a prominent role by suppressing the inflammatory response. Treatments with acetylcholinesterase inhibitors enhance cholinergic transmission and may therefore act as a potential approach to prevent neuroinflammation. In the presence or absence of acetylcholinesterase inhibitors, adult Wistar rats underwent surgery alone or were additionally treated with lipopolysaccharide (LPS). Physostigmine, which can overcome the blood-brain barrier or neostigmine acting only peripheral, served as acetylcholinesterase inhibitors. The expression of pro- and anti-inflammatory cytokines in the cortex, hippocampus, spleen and plasma was measured after 1 h, 24 h, 3 d and 7 d using Real-Time PCR, western blot analysis or cytometric bead array (CBA). Fluoro-Jade B staining of brain slices was employed to elucidate neurodegeneration. The activity of acetylcholinesterase was estimated using a spectrofluorometric method. Surgery accompanied by LPS-treatment led to increased IL-1beta gene and protein upregulation in the cortex and hippocampus but was significantly reduced by physostigmine and neostigmine. Furthermore, surgery in combination with LPS-treatment caused increased protein expression of IL-1, TNF-alpha and IL-10 in the spleen and plasma. Physostigmine and neostigmine significantly decreased the protein expression of IL-1 and TNF-alpha. Neuronal degeneration and the activity of acetylcholinesterase were elevated after surgery with LPS-treatment and reduced by physostigmine and neostigmine. Along with LPS-treatment, acetylcholinesterase inhibitors reduce the pro-inflammatory response as well as neurodegeneration after surgery in the cortex and hippocampus. This combination may represent a tool to break the pathogenesis of POCD.This publication has 59 references indexed in Scilit:
- Intracisternal Interleukin-1 Receptor Antagonist Prevents Postoperative Cognitive Decline and Neuroinflammatory Response in Aged RatsJournal of Neuroscience, 2012
- Neural reflexes in inflammation and immunityThe Journal of Experimental Medicine, 2012
- Acetylcholinesterase Involvement in ApoptosisFrontiers in Molecular Neuroscience, 2012
- Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunctionBioorganic & Medicinal Chemistry Letters, 2010
- The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunctionCritical Care, 2010
- Markers of cerebral damage during delirium in elderly patients with hip fractureBMC Neurology, 2009
- Time course of hippocampal IL-1 β and memory consolidation impairments in aging rats following peripheral infectionBrain, Behavior, and Immunity, 2009
- N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's DiseasePLOS ONE, 2008
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001